Up-Regulation of GLT1 Reverses the Deficit in Cortically Evoked Striatal Ascorbate Efflux in the R6/2 Mouse Model of Huntington’s Disease

Journal of Neurochemistry - United Kingdom
doi 10.1111/j.1471-4159.2012.07691.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ceftriaxone-Induced Up-Regulation of Cortical and Striatal GLT1 in the R6/2 Model of Huntington's Disease

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2010English

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease

PLoS ONE
Multidisciplinary
2016English

Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington’s Disease

PLoS ONE
Multidisciplinary
2015English

Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington’s Disease

Neurotherapeutics
NeurologyPharmacology
2020English

Corticosterone Dysregulation Exacerbates Disease Progression in the R6/2 Transgenic Mouse Model of Huntington's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2016English

CD200 Is Up-Regulated in R6/1 Transgenic Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2019English

Author Correction: Laquinimod Treatment in the R6/2 Mouse Model

Scientific Reports
Multidisciplinary
2019English

Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease

Journal of Neurophysiology
NeurosciencePhysiology
2006English

Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy